Literature DB >> 8925377

The use of anabolic-androgenic steroids by Canadian students.

P Melia1, A Pipe, L Greenberg.   

Abstract

OBJECTIVE: To assess the prevalence of use of anabolic-androgenic steroids and other presumed performance-enhancing drugs and the associated knowledge, attitudes, and behavior of school-aged Canadians.
DESIGN: A national survey was conducted using a self-report questionnaire distributed randomly to schools within each of five Canadian regions.
SETTING: Canada.
SUBJECTS: The subjects were 16,119 Canadian students, in the sixth grade and above, from 107 schools drawn randomly from five Canadian regions. MAIN OUTCOME MEASUREMENTS: The number of students reporting the use of anabolic-androgenic steroids and other performance-enhancing drugs in the year before the survey, the nature of such drug-taking activities, and the attitudes underlying the decision to take anabolic-androgenic steroids.
RESULTS: More than 83,000 young Canadians (2.8% of the respondents) are estimated to have used anabolic-androgenic steroids in the year before the survey. Of those taking such drugs, 29.4% reported that they injected them; of the latter group, 29.2% reported sharing needles in the course of injecting anabolic-androgenic steroids. Significant numbers of respondents reported using other substances (caffeine, 27%; extra protein, 27%; alcohol, 8.6%; painkillers, 9%; stimulants, 3.1%; "doping methods," 2.3%; beta-blockers, 1%) in attempts to improve sport performance.
CONCLUSIONS: The use of anabolic-androgenic steroids is more widespread than may have been assumed and is often accompanied by high-risk needle-sharing. Anabolic-androgenic steroid use is often intended to alter body build as opposed to accentuating sport performance. Many young Canadians use a variety of other substances in attempts to improve sport performance. Drug-taking of this kind represents a special challenge for educators, health professionals, and sport authorities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8925377     DOI: 10.1097/00042752-199601000-00004

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  31 in total

Review 1.  Risk factors associated with anabolic-androgenic steroid use among adolescents.

Authors:  M S Bahrke; C E Yesalis; A N Kopstein; J A Stephens
Journal:  Sports Med       Date:  2000-06       Impact factor: 11.136

2.  Culture, psychosomatics and substance abuse: the example of body image drugs.

Authors:  Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Psychother Psychosom       Date:  2012-01-18       Impact factor: 17.659

3.  Doping use among tertiary education students in six developed countries.

Authors:  Fotios C Papadopoulos; Ilias Skalkidis; Jari Parkkari; Eleni Petridou
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

4.  Pubertal exposure to anabolic androgenic steroids increases spine densities on neurons in the limbic system of male rats.

Authors:  R L Cunningham; B J Claiborne; M Y McGinnis
Journal:  Neuroscience       Date:  2007-09-21       Impact factor: 3.590

5.  Trends in non-medical use of anabolic steroids by U.S. college students: results from four national surveys.

Authors:  Sean Esteban McCabe; Kirk J Brower; Brady T West; Toben F Nelson; Henry Wechsler
Journal:  Drug Alcohol Depend       Date:  2007-05-23       Impact factor: 4.492

6.  Doping prevalence among preadolescent athletes: a 4-year follow-up.

Authors:  P Laure; C Binsinger
Journal:  Br J Sports Med       Date:  2007-05-01       Impact factor: 13.800

Review 7.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

Review 8.  Globalisation of anti-doping: the reverse side of the medal.

Authors:  Bengt Kayser; Aaron C T Smith
Journal:  BMJ       Date:  2008-07-04

9.  Doping, sport and the community.

Authors:  Andrew Pipe; Paul C Hébert
Journal:  CMAJ       Date:  2008-08-12       Impact factor: 8.262

Review 10.  Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.

Authors:  Faidon Magkos; Stavros A Kavouras
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.